ROYAL BANK OF CANADA - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 4 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$0
-100.0%
643
-82.5%
0.00%
Q1 2018$5,000
-16.7%
3,680
-18.3%
0.00%
Q4 2017$6,000
-14.3%
4,506
+52.3%
0.00%
Q3 2017$7,000
+75.0%
2,958
-1.0%
0.00%
Q2 2017$4,000
-33.3%
2,988
-8.5%
0.00%
Q1 2017$6,000
-77.8%
3,266
-46.9%
0.00%
Q4 2016$27,000
+8.0%
6,154
+18.5%
0.00%
Q3 2016$25,000
+108.3%
5,194
+45.4%
0.00%
Q2 2016$12,000
+9.1%
3,573
+11.5%
0.00%
Q1 2016$11,0003,2040.00%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Rubric Capital Management, LLC 237,547$843,00013.09%
JW Asset Management, LLC 1,836,375$6,519,0004.26%
DRILL CRAIG A 339,300$1,205,0003.04%
Tiger Legatus Capital Management, LLC 1,275,000$4,526,0001.80%
Broadfin Capital, LLC 3,800,000$13,490,0001.30%
Healthcare Value Capital, LLC 175,000$621,0000.91%
Kavi Asset Management, LP 313,627$1,113,0000.87%
Healthcare Value Capital, LLC 100,000$355,0000.52%
Elk Creek Partners, LLC 1,392,746$4,944,0000.37%
Par Capital Management 5,365,000$19,046,0000.30%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders